Clinical Trial Update: Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker. [Phase 4]

View source ↗

Summary

A phase 4 clinical trial update evaluating DEXTENZA sustained-release dexamethasone inserts for pain, inflammation, and cystoid macular edema after vitrectomy w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema Associated with Macular Pucker
• Vitrectomy-related Retinal Edema

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

Sponsor: Kovach Eye Institute | Conditions: Vitrectomy, Macular Pucker | Phase 4 | Status: UNKNOWN